Listed

Emergent BioSolutions Inc.

EBSNYSECIK 1367644HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$234.3m, Q2 FY2026
Operating income−$125.1m, Q2 FY2026
Net income−$180.2m, Q2 FY2026
Emergent BioSolutions Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m271Revenue, Q3 FY2023, three months to 2023-09-30$270.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure277Revenue, Q4 FY2023, three months to 2023-12-31$276.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure300Revenue, Q1 FY2024, three months to 2024-03-31$300.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure255Revenue, Q2 FY2024, three months to 2024-06-30$254.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure294Revenue, Q3 FY2024, three months to 2024-09-30$293.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure195Revenue, Q4 FY2024, three months to 2024-12-31$194.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure222Revenue, Q1 FY2025, three months to 2025-03-31$222.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure141Revenue, Q2 FY2025, three months to 2025-06-30$140.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure231Revenue, Q3 FY2025, three months to 2025-09-30$231.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure149Revenue, Q4 FY2025, three months to 2025-12-31$148.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure156Revenue, Q1 FY2026, three months to 2026-03-31$156.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure234Revenue, Q2 FY2026, three months to 2026-06-30$234.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Cost of revenue$m177Cost of revenue, Q3 FY2023, three months to 2023-09-30$176.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure185Cost of revenue, Q4 FY2023, three months to 2023-12-31$185.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure145Cost of revenue, Q1 FY2024, three months to 2024-03-31$144.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure296Cost of revenue, Q2 FY2024, three months to 2024-06-30$296.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure123Cost of revenue, Q3 FY2024, three months to 2024-09-30$122.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure118Cost of revenue, Q4 FY2024, three months to 2024-12-31$118.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure88.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$88.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure66.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$66.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure85.9Cost of revenue, Q3 FY2025, three months to 2025-09-30$85.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure84.9Cost of revenue, Q4 FY2025, three months to 2025-12-31$84.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure72.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$72.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure97.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$97.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Gross profit$m87.2Gross profit, Q3 FY2023, three months to 2023-09-30$87.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure84.8Gross profit, Q4 FY2023, three months to 2023-12-31$84.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-08, accession 0001367644-24-000033. Derived: 12-month figure less the 9-month figure.Report this figure148Gross profit, Q1 FY2024, three months to 2024-03-31$147.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure(48.0)Gross profit, Q2 FY2024, three months to 2024-06-30−$48.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-08-07, accession 0001367644-24-000147.Report this figure161Gross profit, Q3 FY2024, three months to 2024-09-30$161.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m15.3Research and development, Q3 FY2023, three months to 2023-09-30$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure29.4Research and development, Q4 FY2023, three months to 2023-12-31$29.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure15.1Research and development, Q1 FY2024, three months to 2024-03-31$15.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure32.7Research and development, Q2 FY2024, three months to 2024-06-30$32.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure13.8Research and development, Q3 FY2024, three months to 2024-09-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure9.1Research and development, Q4 FY2024, three months to 2024-12-31$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure15.1Research and development, Q1 FY2025, three months to 2025-03-31$15.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure12.5Research and development, Q2 FY2025, three months to 2025-06-30$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure13.5Research and development, Q3 FY2025, three months to 2025-09-30$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure12.1Research and development, Q4 FY2025, three months to 2025-12-31$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure10.5Research and development, Q1 FY2026, three months to 2026-03-31$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure9.2Research and development, Q2 FY2026, three months to 2026-06-30$9.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Selling, general and administrative$m86.0Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$86.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure89.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$89.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure84.7Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$84.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure85.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$85.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure76.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$76.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure60.8Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$60.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure52.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$52.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure43.7Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$43.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure38.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$38.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure51.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$51.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure46.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$46.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure44.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$44.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Operating income$m(242)Operating income, Q3 FY2023, three months to 2023-09-30−$242.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure(43.8)Operating income, Q4 FY2023, three months to 2023-12-31−$43.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure39.8Operating income, Q1 FY2024, three months to 2024-03-31$39.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure(204)Operating income, Q2 FY2024, three months to 2024-06-30−$203.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure64.5Operating income, Q3 FY2024, three months to 2024-09-30$64.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure(9.5)Operating income, Q4 FY2024, three months to 2024-12-31−$9.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure49.9Operating income, Q1 FY2025, three months to 2025-03-31$49.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure1.6Operating income, Q2 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure76.5Operating income, Q3 FY2025, three months to 2025-09-30$76.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure(27.9)Operating income, Q4 FY2025, three months to 2025-12-31−$27.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure10.5Operating income, Q1 FY2026, three months to 2026-03-31$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure(125)Operating income, Q2 FY2026, three months to 2026-06-30−$125.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Interest expense$m19.7Interest expense, Q3 FY2023, three months to 2023-09-30$19.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-12-11, accession 0001367644-23-000208.Report this figure21.7Interest expense, Q4 FY2023, three months to 2023-12-31$21.7m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-08, accession 0001367644-24-000033. Derived: 12-month figure less the 9-month figure.Report this figure24.3Interest expense, Q1 FY2024, three months to 2024-03-31$24.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure23.6Interest expense, Q2 FY2024, three months to 2024-06-30$23.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure8.3Interest expense, Q3 FY2024, three months to 2024-09-30$8.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure14.8Interest expense, Q4 FY2024, three months to 2024-12-31$14.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure14.7Interest expense, Q1 FY2025, three months to 2025-03-31$14.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure14.7Interest expense, Q2 FY2025, three months to 2025-06-30$14.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure15.2Interest expense, Q3 FY2025, three months to 2025-09-30$15.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure14.7Interest expense, Q4 FY2025, three months to 2025-12-31$14.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure11.0Interest expense, Q1 FY2026, three months to 2026-03-31$11.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure10.0Interest expense, Q2 FY2026, three months to 2026-06-30$10.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Income tax$m(2.5)Income tax, Q3 FY2023, three months to 2023-09-30−$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure(5.0)Income tax, Q4 FY2023, three months to 2023-12-31−$5.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure3.1Income tax, Q1 FY2024, three months to 2024-03-31$3.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure13.3Income tax, Q2 FY2024, three months to 2024-06-30$13.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure27.6Income tax, Q3 FY2024, three months to 2024-09-30$27.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure3.7Income tax, Q4 FY2024, three months to 2024-12-31$3.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure24.7Income tax, Q1 FY2025, three months to 2025-03-31$24.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure(4.8)Income tax, Q2 FY2025, three months to 2025-06-30−$4.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure6.4Income tax, Q3 FY2025, three months to 2025-09-30$6.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure3.9Income tax, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure6.6Income tax, Q1 FY2026, three months to 2026-03-31$6.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure13.9Income tax, Q2 FY2026, three months to 2026-06-30$13.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Net income$m(263)Net income, Q3 FY2023, three months to 2023-09-30−$263.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure(49.5)Net income, Q4 FY2023, three months to 2023-12-31−$49.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure9.0Net income, Q1 FY2024, three months to 2024-03-31$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure(283)Net income, Q2 FY2024, three months to 2024-06-30−$283.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure115Net income, Q3 FY2024, three months to 2024-09-30$114.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure(31.3)Net income, Q4 FY2024, three months to 2024-12-31−$31.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure68.0Net income, Q1 FY2025, three months to 2025-03-31$68.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure(12.0)Net income, Q2 FY2025, three months to 2025-06-30−$12.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure51.2Net income, Q3 FY2025, three months to 2025-09-30$51.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure(54.6)Net income, Q4 FY2025, three months to 2025-12-31−$54.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure6.8Net income, Q1 FY2026, three months to 2026-03-31$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure(180)Net income, Q2 FY2026, three months to 2026-06-30−$180.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Diluted EPS$ per share(5.08)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$5.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figurenot reported0.17Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure(5.38)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$5.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure2.06Diluted EPS, Q3 FY2024, three months to 2024-09-30$2.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figurenot reported1.19Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure(0.22)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure0.91Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figurenot reported0.07Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure(3.49)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$3.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Basic EPS$ per share(5.08)Basic EPS, Q3 FY2023, three months to 2023-09-30−$5.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figurenot reported0.17Basic EPS, Q1 FY2024, three months to 2024-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure(5.38)Basic EPS, Q2 FY2024, three months to 2024-06-30−$5.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure2.16Basic EPS, Q3 FY2024, three months to 2024-09-30$2.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figurenot reported1.25Basic EPS, Q1 FY2025, three months to 2025-03-31$1.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure(0.22)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure0.96Basic EPS, Q3 FY2025, three months to 2025-09-30$0.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figurenot reported0.13Basic EPS, Q1 FY2026, three months to 2026-03-31$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure(3.49)Basic EPS, Q2 FY2026, three months to 2026-06-30−$3.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure

Balance sheet

Cash and equivalents$139.7m, Q2 FY2026
Long-term debt$581.8m, Q2 FY2026
Shareholders' equity$341.4m, Q2 FY2026
Emergent BioSolutions Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m87.8Cash and equivalents, Q3 FY2023, at 2023-09-30$87.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure112Cash and equivalents, FY2023, at 2023-12-31$111.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001367644-26-000015.Report this figure78.5Cash and equivalents, Q1 FY2024, at 2024-03-31$78.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure69.7Cash and equivalents, Q2 FY2024, at 2024-06-30$69.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure150Cash and equivalents, Q3 FY2024, at 2024-09-30$149.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure99.5Cash and equivalents, FY2024, at 2024-12-31$99.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001367644-26-000015.Report this figure149Cash and equivalents, Q1 FY2025, at 2025-03-31$149.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure267Cash and equivalents, Q2 FY2025, at 2025-06-30$267.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure246Cash and equivalents, Q3 FY2025, at 2025-09-30$245.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure205Cash and equivalents, FY2025, at 2025-12-31$205.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure160Cash and equivalents, Q1 FY2026, at 2026-03-31$160.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure140Cash and equivalents, Q2 FY2026, at 2026-06-30$139.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Current assets$m721Current assets, Q3 FY2023, at 2023-09-30$720.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-12-11, accession 0001367644-23-000208.Report this figure680Current assets, FY2023, at 2023-12-31$679.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-04, accession 0001367644-25-000021.Report this figure682Current assets, Q1 FY2024, at 2024-03-31$682.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure655Current assets, Q2 FY2024, at 2024-06-30$654.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001367644-24-000147.Report this figure661Current assets, Q3 FY2024, at 2024-09-30$661.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure599Current assets, FY2024, at 2024-12-31$598.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-27, accession 0001367644-26-000015.Report this figure707Current assets, Q1 FY2025, at 2025-03-31$706.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure720Current assets, Q2 FY2025, at 2025-06-30$719.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure787Current assets, Q3 FY2025, at 2025-09-30$786.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure663Current assets, FY2025, at 2025-12-31$662.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure638Current assets, Q1 FY2026, at 2026-03-31$637.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure666Current assets, Q2 FY2026, at 2026-06-30$666.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Total assets$m1,893Total assets, Q3 FY2023, at 2023-09-30$1.89bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-12-11, accession 0001367644-23-000208.Report this figure1,823Total assets, FY2023, at 2023-12-31$1.82bn. XBRL concept us-gaap:Assets. 10-K filed 2025-03-04, accession 0001367644-25-000021.Report this figure1,804Total assets, Q1 FY2024, at 2024-03-31$1.80bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure1,514Total assets, Q2 FY2024, at 2024-06-30$1.51bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001367644-24-000147.Report this figure1,478Total assets, Q3 FY2024, at 2024-09-30$1.48bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure1,390Total assets, FY2024, at 2024-12-31$1.39bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001367644-26-000015.Report this figure1,426Total assets, Q1 FY2025, at 2025-03-31$1.43bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure1,417Total assets, Q2 FY2025, at 2025-06-30$1.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure1,461Total assets, Q3 FY2025, at 2025-09-30$1.46bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure1,319Total assets, FY2025, at 2025-12-31$1.32bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure1,320Total assets, Q1 FY2026, at 2026-03-31$1.32bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure1,117Total assets, Q2 FY2026, at 2026-06-30$1.12bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Current liabilities$m664Current liabilities, Q3 FY2023, at 2023-09-30$664.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-12-11, accession 0001367644-23-000208.Report this figure651Current liabilities, FY2023, at 2023-12-31$651.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-04, accession 0001367644-25-000021.Report this figure630Current liabilities, Q1 FY2024, at 2024-03-31$630.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure620Current liabilities, Q2 FY2024, at 2024-06-30$619.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001367644-24-000147.Report this figure230Current liabilities, Q3 FY2024, at 2024-09-30$229.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure162Current liabilities, FY2024, at 2024-12-31$162.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-27, accession 0001367644-26-000015.Report this figure112Current liabilities, Q1 FY2025, at 2025-03-31$111.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure127Current liabilities, Q2 FY2025, at 2025-06-30$127.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure137Current liabilities, Q3 FY2025, at 2025-09-30$136.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure132Current liabilities, FY2025, at 2025-12-31$132.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure149Current liabilities, Q1 FY2026, at 2026-03-31$148.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure123Current liabilities, Q2 FY2026, at 2026-06-30$122.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Total liabilities$m1,196Total liabilities, Q3 FY2023, at 2023-09-30$1.20bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-12-11, accession 0001367644-23-000208.Report this figure1,174Total liabilities, FY2023, at 2023-12-31$1.17bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-04, accession 0001367644-25-000021.Report this figure1,140Total liabilities, Q1 FY2024, at 2024-03-31$1.14bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure1,127Total liabilities, Q2 FY2024, at 2024-06-30$1.13bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001367644-24-000147.Report this figure969Total liabilities, Q3 FY2024, at 2024-09-30$969.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure907Total liabilities, FY2024, at 2024-12-31$906.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-27, accession 0001367644-26-000015.Report this figure873Total liabilities, Q1 FY2025, at 2025-03-31$873.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure881Total liabilities, Q2 FY2025, at 2025-06-30$880.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure879Total liabilities, Q3 FY2025, at 2025-09-30$878.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure796Total liabilities, FY2025, at 2025-12-31$796.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure797Total liabilities, Q1 FY2026, at 2026-03-31$797.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure775Total liabilities, Q2 FY2026, at 2026-06-30$775.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Long-term debt$m448Long-term debt, Q3 FY2023, at 2023-09-30$448.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-12-11, accession 0001367644-23-000208.Report this figure447Long-term debt, FY2023, at 2023-12-31$446.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-04, accession 0001367644-25-000021.Report this figure447Long-term debt, Q1 FY2024, at 2024-03-31$446.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure447Long-term debt, Q2 FY2024, at 2024-06-30$447.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-07, accession 0001367644-24-000147.Report this figure662Long-term debt, Q3 FY2024, at 2024-09-30$661.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure664Long-term debt, FY2024, at 2024-12-31$663.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-27, accession 0001367644-26-000015.Report this figure666Long-term debt, Q1 FY2025, at 2025-03-31$665.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure668Long-term debt, Q2 FY2025, at 2025-06-30$667.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure663Long-term debt, Q3 FY2025, at 2025-09-30$663.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure572Long-term debt, FY2025, at 2025-12-31$572.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure574Long-term debt, Q1 FY2026, at 2026-03-31$573.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure582Long-term debt, Q2 FY2026, at 2026-06-30$581.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure
Current portion of debt$m414Current portion of debt, Q3 FY2023, at 2023-09-30$413.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-12-11, accession 0001367644-23-000208.Report this figure414Current portion of debt, FY2023, at 2023-12-31$413.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-04, accession 0001367644-25-000021.Report this figure459Current portion of debt, Q1 FY2024, at 2024-03-31$459.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure415Current portion of debt, Q2 FY2024, at 2024-06-30$415.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-07, accession 0001367644-24-000147.Report this figure0.8Current portion of debt, Q3 FY2024, at 2024-09-30$800.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-04, accession 0001367644-25-000021.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m697Shareholders' equity, Q3 FY2023, at 2023-09-30$697.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure649Shareholders' equity, FY2023, at 2023-12-31$649.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-27, accession 0001367644-26-000015.Report this figure664Shareholders' equity, Q1 FY2024, at 2024-03-31$663.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure386Shareholders' equity, Q2 FY2024, at 2024-06-30$386.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure508Shareholders' equity, Q3 FY2024, at 2024-09-30$508.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure483Shareholders' equity, FY2024, at 2024-12-31$482.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure553Shareholders' equity, Q1 FY2025, at 2025-03-31$552.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure536Shareholders' equity, Q2 FY2025, at 2025-06-30$536.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure583Shareholders' equity, Q3 FY2025, at 2025-09-30$582.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure523Shareholders' equity, FY2025, at 2025-12-31$522.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure523Shareholders' equity, Q1 FY2026, at 2026-03-31$523.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure341Shareholders' equity, Q2 FY2026, at 2026-06-30$341.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure

Cash flow

Operating cash flow$56.1m, Q2 FY2026
Capital expenditure$2.1m, Q2 FY2026
Share repurchases$9.0m, Q2 FY2026
Emergent BioSolutions Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m60.0Operating cash flow, Q3 FY2023, three months to 2023-09-30$60.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001367644-24-000178. Derived: 9-month figure less the 6-month figure.Report this figure32.1Operating cash flow, Q4 FY2023, three months to 2023-12-31$32.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(62.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$62.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure47.5Operating cash flow, Q2 FY2024, three months to 2024-06-30$47.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001367644-25-000181. Derived: 6-month figure less the 3-month figure.Report this figure154Operating cash flow, Q3 FY2024, three months to 2024-09-30$153.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001367644-25-000202. Derived: 9-month figure less the 6-month figure.Report this figure(79.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$79.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(11.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$11.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure106Operating cash flow, Q2 FY2025, three months to 2025-06-30$106.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001367644-26-000082. Derived: 6-month figure less the 3-month figure.Report this figure(2.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001367644-25-000202. Derived: 9-month figure less the 6-month figure.Report this figure77.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$77.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(33.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$33.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure56.1Operating cash flow, Q2 FY2026, three months to 2026-06-30$56.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001367644-26-000082. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m12.6Capital expenditure, Q3 FY2023, three months to 2023-09-30$12.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001367644-24-000178. Derived: 9-month figure less the 6-month figure.Report this figure11.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$11.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure10.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$10.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure4.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$4.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001367644-25-000181. Derived: 6-month figure less the 3-month figure.Report this figure5.8Capital expenditure, Q3 FY2024, three months to 2024-09-30$5.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001367644-25-000202. Derived: 9-month figure less the 6-month figure.Report this figure1.7Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure3.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure2.9Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001367644-26-000082. Derived: 6-month figure less the 3-month figure.Report this figure3.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001367644-25-000202. Derived: 9-month figure less the 6-month figure.Report this figure3.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure2.4Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure2.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001367644-26-000082. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2023-12-11, accession 0001367644-23-000208. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-30, accession 0001367644-25-000202. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure6.9Share repurchases, Q2 FY2025, three months to 2025-06-30$6.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001367644-26-000082. Derived: 6-month figure less the 3-month figure.Report this figure8.9Share repurchases, Q3 FY2025, three months to 2025-09-30$8.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-30, accession 0001367644-25-000202. Derived: 9-month figure less the 6-month figure.Report this figure9.1Share repurchases, Q4 FY2025, three months to 2025-12-31$9.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001367644-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure9.0Share repurchases, Q1 FY2026, three months to 2026-03-31$9.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure9.0Share repurchases, Q2 FY2026, three months to 2026-06-30$9.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-06, accession 0001367644-26-000082. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)51.60m, Q2 FY2026
Emergent BioSolutions Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares49.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3049,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-12-11, accession 0001367644-23-000208.Report this figure50.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3150,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001367644-24-000063.Report this figure50.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3050,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001367644-24-000147.Report this figure51.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3051,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001367644-24-000178.Report this figure52.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3152,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001367644-25-000124.Report this figure52.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3052,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001367644-25-000181.Report this figure55.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3055,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure57.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3157,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure54.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3054,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure56.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3056,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001367644-25-000202.Report this figure56.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3156,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-01, accession 0001367644-26-000065.Report this figure51.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3051,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure

Shares outstanding: 51.27mShares outstanding, period not labelled, at 2026-07-3051,273,336 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001367644-26-000082.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.